Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Alpa Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Disclosure Of Voting Results Along With Scrutinizer Report
Alpa Laboratories has submitted the disclosure under regulation 44 of SEBI Listing Obligations and Disclosure Requirements Book Closure For Annual General Meeting And Period Of E Voting Cycle.
Kindly Take A Note Of The Book Closure Dates For Annual General Meeting And Period Of E Voting Cycle. Board Meeting Intimation for Quarterly Results As On June 20,2018 And Closure Of Trading Window.
ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2018 ,inter alias, to consider and approve 1. To Consider the Unaudited Financial Results for the quarter ended June 30,2018. 2. To Approve the Notice of 30th Annual General Meeting of the company. Submission Of Consolidated Auditor''s Report For The Quarter And Period Ended March 31,2018.
Alpa Laboratories has submitted the Consolidated Auditor''s Report for the quarter and period ended March 31,2018. Shareholding for the Period Ended June 30, 2018
Alpa Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- MEGHA NEEMADesignation :- Company Secretary and Compliance Officer Outcome Of Board Meeting Under Regulation 33 Of SEBI LODR,2015.
ALPA Laboratories has submitted the quarter and year ended 2018 results. Intimation Under Regulation 33 (B) (I)Of SEBI Listing Obligations And Disclosure Requirements.
Alpa Laboratories has submitted the disclosure under regulation 33 (b) (i)of SEBI Listing Obligations and Disclosure requirements.